AMProtein Corporation Patent applications |
Patent application number | Title | Published |
20100216188 | USE OF CHICK BETA ACTIN GENE INTRON-1 - A method to use chick beta actin gene intron-1 or functional equivalent as a gene expression enhancer element or a gene expression “hot spot” sequence for constructing or reconstructing a mammalian expression vector for extremely high expression of recombinant proteins is disclosed. Composition of a set of extremely strong gene expression vectors is also disclosed. | 08-26-2010 |
20100190245 | METHOD TO INCREASE DISSOLVED OXYGEN IN A CULTURE VESSEL - Basing on study of a previous discovered effective bioreactor system, a method to increase culture medium dissolved oxygen is disclosed. This method together with addition of an optimal mixing forms a theoretical foundation for effective bioreactor design and prototype construction. | 07-29-2010 |
20100076380 | BIOREACTORS - Disclosed are various examples of methods and systems for providing an oxygenated culture environment for growing animal cells, as well as methods and systems for oxygenating blood and related methods for treating diseases and related conditions. | 03-25-2010 |
20090175795 | CHIMERIC THERAPEUTIC AGENTS - A fusion protein including (i) a first segment that is located at the amino terminus of the fusion protein and contains the sequence of a first biological active peptide or protein; and (ii) a second segment that is located at the carboxyl terminus of the fusion protein and contains the sequence of a second biological active peptide or protein. The first and second segments are operably and covalently linked. Also disclosed are nucleic acids encoding the fusion protein, vectors and host cells having the nucleic acids, and related composition and methods of treating diabetes or/and obesity. | 07-09-2009 |
20080292628 | Chimeric Protein - A fusion protein containing a first segment that is located at the amino terminus of the fusion protein and specifically binds to and neutralizes a first cytokine or growth factor; and a second segment that is located at the carboxyl terminus of the fusion protein and specifically binds to a second cytokine receptor which is often rich at disease sites such as IL-1 receptor-rich inflammatory site. In addition, the said second segment is usually the receptor antagonist such as IL-1 receptor antagonist and its functional equivalent analogues. Also disclosed are nucleic acids encoding the fusion protein, vectors and host cells having the nucleic acids, and related composition and methods to target inflammatory diseases and indications co-existed with inflammation. | 11-27-2008 |
20080199958 | Suspension Culture Vessels - A cell culture vessel comprising a housing chamber which has an inverted frusto-conical bottom having a vertical axis. The culture vessel further comprises an upper and lower section which are concentric. The vessel requires little or no shear-force and less stress by shaking or impellor action. | 08-21-2008 |